Juan Luis
García Hernández
Ikertzailea 2011-(e)tik
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes
PLoS ONE, Vol. 11, Núm. 10